Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

SambrinvestLatest Sep 21

Novadip Biosciences · €10.4M Convertible financing Brenus Pharma · €11M Series A

3rounds

0led

Biotech 3

Seed 1, Series A 1, Undisclosed 1

Sep 21, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Undisclosed 1

Novadip Biosciences €10.4M Convertible financing Brenus Pharma €11M Series A Enodia Therapeutics €20.7M Seed

Kadmos CapitalLatest Sep 17

Big Picture Bio · £2.2M Pre-seed and Innovate UK grant package Antiverse · $9.3M Series A

3rounds

1led

Biotech 2Healthtech 1

Pre-seed 1, Seed 1, Series A 1

Sep 17, 2026

Details

New companies 3 · Follow-on 0

Stages: Pre-seed 1, Seed 1, Series A 1

Big Picture Bio £2.2M Pre-seed and Innovate UK grant package Antiverse $9.3M Series A OutSee £2.5M Seed

Quiet CapitalLatest Sep 17

Polyphron · $20M Seed Science Corporation · $230M Series C

3rounds

1led

Biotech 2Healthtech 1

Series C+ 2, Seed 1

Sep 17, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Seed 1

Polyphron $20M Seed Science Corporation $230M Series C Loyal $100M Series C

5Y CapitalLatest Sep 16

Anew Labs · $290M Funding Syneron Bio · $150M Series B

3rounds

1led

Biotech 3

Seed 1, Series B 1, Undisclosed 1

Sep 16, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series B 1, Undisclosed 1

Anew Labs $290M Funding Syneron Bio $150M Series B Excalipoint Therapeutics $27.7M Seed+

Euclidean CapitalLatest Sep 16

Circle Pharma, Inc. · $92.5M Series E Leal Therapeutics · $30M Series A

3rounds

0led

Biotech 3

Series A 1, Series B 1, Series C+ 1

Sep 16, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 1, Series B 1, Series C+ 1

Circle Pharma, Inc. $92.5M Series E Leal Therapeutics $30M Series A InduPro $77M Series B

Gaorong VenturesLatest Sep 16

Anew Labs · $290M Funding Moonwalk Biosciences · $70M Series B

3rounds

0led

Biotech 2Healthtech 1

Series A 1, Series B 1, Undisclosed 1

Sep 16, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 1, Series B 1, Undisclosed 1

Anew Labs $290M Funding Moonwalk Biosciences $70M Series B Axoft $55M Series A

GL VenturesLatest Sep 16

Anew Labs · $290M Funding LTZ Therapeutics · $38M Undisclosed

3rounds

1led

Biotech 3

Undisclosed 2, Series B 1

Sep 16, 2026

Details

New companies 3 · Follow-on 0

Stages: Undisclosed 2, Series B 1

Anew Labs $290M Funding LTZ Therapeutics $38M Undisclosed Syneron Bio $150M Series B

HSGLatest Sep 16

Anew Labs · $290M Funding Full-Life Technologies · $150M Series D+Debt

3rounds

1led

Biotech 3

Undisclosed 2, Series A 1

Sep 16, 2026

Details

New companies 3 · Follow-on 0

Stages: Undisclosed 2, Series A 1

Anew Labs $290M Funding Full-Life Technologies $150M Series D+Debt Vibrant Therapeutics $61M Series A

Nextech InvestLatest Sep 16

Circle Pharma, Inc. · $92.5M Series E Khartis Therapeutics · $50M Series B

3rounds

0led

Biotech 3

Series C+ 2, Series B 1

Sep 16, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Series B 1

Circle Pharma, Inc. $92.5M Series E Khartis Therapeutics $50M Series B Parabilis Medicines $305M Series F

100

Obvious VenturesLatest Sep 16

Mithrl · $20M Series A Radical Numerics · $50M Seed

3rounds

1led

AI 1Biotech 1Healthtech 1

Seed 1, Series A 1, Series C+ 1

Sep 16, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Series C+ 1

Mithrl $20M Series A Radical Numerics $50M Seed Iterative Health $77M Series C

101

Labcorp Venture FundLatest Sep 15

Evvy · $40M Series B Prenosis · $20M Series A

3rounds

0led

Biotech 2Healthtech 1

Series A 1, Series B 1, Undisclosed 1

Sep 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 1, Series B 1, Undisclosed 1

Evvy $40M Series B Prenosis $20M Series A BIOMAKERS $8M Undisclosed

102

Playground GlobalLatest Sep 15

RegCell, Inc. · $44M Series A Infinimmune · $75M Series A

3rounds

1led

Biotech 2AI 1

Series A 2, Seed 1

Sep 15, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Seed 1

RegCell, Inc. $44M Series A Infinimmune $75M Series A Unreasonable Labs $13.5M Seed

103

DCVCLatest Sep 14

Shennon Biotechnologies · $12M Funding Kanvas Biosciences · $48M Series A

3rounds

0led

Biotech 3

Undisclosed 2, Series A 1

Sep 14, 2026

Details

New companies 3 · Follow-on 0

Stages: Undisclosed 2, Series A 1

Shennon Biotechnologies $12M Funding Kanvas Biosciences $48M Series A Proxima $80M Undisclosed

104

Innovate UKLatest Sep 14

Athernal Bio · ~£700K Grant Respiro Diagnostics · £1M Pre-Seed

3rounds

0led

Biotech 2Healthtech 1

Pre-seed 1, Seed 1, Undisclosed 1

Sep 14, 2026

Details

New companies 3 · Follow-on 0

Stages: Pre-seed 1, Seed 1, Undisclosed 1

Athernal Bio ~£700K Grant Respiro Diagnostics £1M Pre-Seed QuberTech £3.4M Seed

105

Canaan PartnersLatest Sep 9

Solstice Oncology · $225M Series A Draig Therapeutics · $65M Series B

3rounds

0led

Biotech 3

Series A 2, Series B 1

Sep 9, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Series B 1

Solstice Oncology $225M Series A Draig Therapeutics $65M Series B Vedana Therapeutics $46M Series A

106

Farallon Capital ManagementLatest Sep 9

Encoded Therapeutics Inc. · $275M Series F Mirador Therapeutics · $250M Series B

3rounds

0led

Biotech 3

Series C+ 2, Series B 1

Sep 9, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Series B 1

Encoded Therapeutics Inc. $275M Series F Mirador Therapeutics $250M Series B Parabilis Medicines $305M Series F

107

NFXLatest Sep 9

TwoStep Therapeutics · $62.5M Series A Remepy · $36M Series A

3rounds

—led

Biotech 3

Series A 2, Undisclosed 1

Sep 9, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Undisclosed 1

TwoStep Therapeutics $62.5M Series A Remepy $36M Series A Portal Biotechnologies $9M Undisclosed

108

American Cancer Society BrightEdgeLatest Sep 8

Cloverleaf Bio · $33M Seed CellCentric · $220M Series D

3rounds

0led

Biotech 3

Seed 2, Series C+ 1

Sep 8, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 2, Series C+ 1

Cloverleaf Bio $33M Seed CellCentric $220M Series D TippingPoint Biosciences $4.5M Seed

109

YuanBio Venture CapitalLatest Aug 27

AusperBio · $120M Series C Beyang Therapeutics · $30M Series A

3rounds

—led

Biotech 3

Series A 2, Series C+ 1

Aug 27, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Series C+ 1

AusperBio $120M Series C Beyang Therapeutics $30M Series A CORE Biomedicine $21M Series A

110

Founders FundLatest Aug 19

Network Bio · $50M Strategic Gamgee · $4M Seed

3rounds

1led

Biotech 3

Seed 1, Series C+ 1, Undisclosed 1

Aug 19, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series C+ 1, Undisclosed 1

Network Bio $50M Strategic Gamgee $4M Seed Alloy Therapeutics $40M Series E

111

abrdnLatest Aug 18

Abcuro · $66M Series D Epicrispr Biotechnologies · $90M Series C

3rounds

—led

Biotech 3

Series C+ 2, Series A 1

Aug 18, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Series A 1

Abcuro $66M Series D Epicrispr Biotechnologies $90M Series C Third Arc Bio $52M Series A+

112

Rock Springs CapitalLatest Aug 18

Abcuro · $66M Series D City Therapeutics · $99.5M Series B

3rounds

—led

Biotech 3

Series C+ 2, Series B 1

Aug 18, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Series B 1

Abcuro $66M Series D City Therapeutics $99.5M Series B Parabilis Medicines $305M Series F

113

Soleus CapitalLatest Aug 18

Abcuro · $66M Series D Crystalys Therapeutics · $130M Series B

3rounds

—led

Biotech 3

Series C+ 2, Series B 1

Aug 18, 2026

Details

New companies 3 · Follow-on 0

Stages: Series C+ 2, Series B 1

Abcuro $66M Series D Crystalys Therapeutics $130M Series B Parabilis Medicines $305M Series F

114

Forge Life Science PartnersLatest Aug 13

Khartis Therapeutics · $50M Series B Infinimmune · $75M Series A

3rounds

—led

Biotech 3

Series B 2, Series A 1

Aug 13, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 2, Series A 1

Khartis Therapeutics $50M Series B Infinimmune $75M Series A Kinaset Therapeutics $103M Series B

115

Longwood FundLatest Aug 13

Khartis Therapeutics · $50M Series B Sidewinder Therapeutics · $137M Series B

3rounds

—led

Biotech 3

Series B 3

Aug 13, 2026

Details

New companies 3 · Follow-on 0

Stages: Series B 3

Khartis Therapeutics $50M Series B Sidewinder Therapeutics $137M Series B Mediar Therapeutics $76M Series B

116

Omega FundsLatest Aug 11

Vaderis Therapeutics · $152M Series B Third Arc Bio · $52M Series A+

3rounds

—led

Biotech 3

Series A 2, Series B 1

Aug 11, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Series B 1

Vaderis Therapeutics $152M Series B Third Arc Bio $52M Series A+Caldera Therapeutics $37.5M Series A1

117

Regeneron VenturesLatest Aug 11

Infinimmune · $75M Series A City Therapeutics · $99.5M Series B

3rounds

—led

Biotech 3

Series A 2, Series B 1

Aug 11, 2026

Details

New companies 3 · Follow-on 0

Stages: Series A 2, Series B 1

Infinimmune $75M Series A City Therapeutics $99.5M Series B Think Bioscience $55M Series A

118

Lifespan Vision VenturesLatest Aug 10

Remedium Bio · $10M Series A Violet Therapeutics · $4.8M Seed+

3rounds

—led

Biotech 3

Pre-seed 1, Seed 1, Series A 1

Aug 10, 2026

Details

New companies 3 · Follow-on 0

Stages: Pre-seed 1, Seed 1, Series A 1

Remedium Bio $10M Series A Violet Therapeutics $4.8M Seed+Sift Biosciences $3.7M Pre-Seed

119

AMR Action FundLatest Aug 5

Vedanta Biosciences · $60M Growth Trellis Bioscience · $9M Series C

3rounds

—led

Biotech 3

Growth 1, Series A 1, Series C+ 1

Aug 5, 2026

Details

New companies 3 · Follow-on 0

Stages: Growth 1, Series A 1, Series C+ 1

Vedanta Biosciences $60M Growth Trellis Bioscience $9M Series C Centauri Therapeutics £6M Series A+

120

Elikon VentureLatest Jul 28

CORE Biomedicine · $21M Series A Fortitude Biomedicines · $13M Seed

3rounds

—led

Biotech 3

Seed 1, Series A 1, Series C+ 1

Jul 28, 2026

Details

New companies 3 · Follow-on 0

Stages: Seed 1, Series A 1, Series C+ 1

CORE Biomedicine $21M Series A Fortitude Biomedicines $13M Seed Oricell Therapeutics $70M Series C1

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.